Healthcare · Hepatitis C prevalence
In 2026, the proportion of hepatitis C carriers in the United States reached 0.9 %, placing the country 85-th globally. The epidemic has two waves: the first occurred in the 1960s–1980s through blood transfusions before screening was introduced; the second, ongoing wave is linked to the opioid crisis and intravenous drug use in rural Appalachia and New England. The advent of highly effective direct-acting antivirals since 2013 has dramatically changed the outlook, but treatment coverage remains uneven.
Data for 2026 · unit: %
Position
#85 / 197
USA world ranking
Country position on the scale from last to first place for this indicator.
US
#85
#197#1
Trend
Change over time
Change in indicator over the available period.
1.5
1990
1.8
2000
1.3
2010
1.0
2020
0.9
2026
Values — %
Comparison
Top countries by Hepatitis C prevalence
Where USA stands in the world ranking.
1
ATAustria
0.1
1
ISIceland
0.1
3
DKDenmark
0.2
3
BEBelgium
0.2
3
NONorway
0.2
3
MTMalta
0.2
3
LULuxembourg
0.2
3
LILiechtenstein
0.2
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Hepatitis C prevalence in USA — how much?
Based on 2026 data — 0.9 %. This is rank #85 out of 197 countries.
What is USA's rank by Hepatitis C prevalence?
USA ranks #85 out of 197 countries in the world ranking by «Hepatitis C prevalence».
How has Hepatitis C prevalence changed in USA?
Over the available period the indicator changed from 1.5 to 0.9 %.